Business Description
Guangdong Marubi Biotechnology Co Ltd
ISIN : CNE100003M51
Share Class Description:
SHSE:603983: Class ATotal Employee Number:
1,380Compare
Compare
Traded in other countries / regions
603983.China Index Membership
SSE Composite IndexCSI 500 Index IPO Date
2019-07-25Description
Guangdong Marubi Biotechnology Co Ltd is engaged in the research and development, design, production, sales and service of various types of cosmetics.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.53 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | 1.82 | |||||
Interest Coverage | 42.04 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 8.22 | |||||
Beneish M-Score | -2.82 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 26.6 | |||||
3-Year EBITDA Growth Rate | 15.9 | |||||
3-Year EPS without NRI Growth Rate | 19.5 | |||||
3-Year Book Growth Rate | 1.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 23.1 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 14.03 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.5 | |||||
9-Day RSI | 41.81 | |||||
14-Day RSI | 47.26 | |||||
3-1 Month Momentum % | 11.8 | |||||
6-1 Month Momentum % | -10.72 | |||||
12-1 Month Momentum % | -29.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.97 | |||||
Quick Ratio | 1.77 | |||||
Cash Ratio | 1.41 | |||||
Days Inventory | 97.34 | |||||
Days Sales Outstanding | 3.53 | |||||
Days Payable | 117.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.66 | |||||
Dividend Payout Ratio | 1.4 | |||||
3-Year Dividend Growth Rate | 58 | |||||
Forward Dividend Yield % | 1.66 | |||||
5-Year Yield-on-Cost % | 3.86 | |||||
Shareholder Yield % | 1.22 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 73.74 | |||||
Operating Margin % | 6.14 | |||||
Net Margin % | 6.1 | |||||
EBITDA Margin % | 7.38 | |||||
FCF Margin % | 3.58 | |||||
OCF Margin % | 9.69 | |||||
ROE % | 6.29 | |||||
ROA % | 4.5 | |||||
ROIC % | 6.07 | |||||
3-Year ROIIC % | 8.33 | |||||
ROC (Joel Greenblatt) % | 26.12 | |||||
ROCE % | 7.42 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 54.72 | |||||
Forward PE Ratio | 34.57 | |||||
PE Ratio without NRI | 54.21 | |||||
Shiller PE Ratio | 31.87 | |||||
Price-to-Owner-Earnings | 591.83 | |||||
PS Ratio | 3.33 | |||||
PB Ratio | 3.39 | |||||
Price-to-Tangible-Book | 3.83 | |||||
Price-to-Free-Cash-Flow | 97.65 | |||||
Price-to-Operating-Cash-Flow | 34.91 | |||||
EV-to-EBIT | 42.56 | |||||
EV-to-Forward-EBIT | 36.48 | |||||
EV-to-EBITDA | 42.56 | |||||
EV-to-Forward-EBITDA | 30.97 | |||||
EV-to-Revenue | 3.14 | |||||
EV-to-Forward-Revenue | 2.84 | |||||
EV-to-FCF | 87.76 | |||||
Price-to-GF-Value | 0.64 | |||||
Price-to-Projected-FCF | 7.06 | |||||
Price-to-Graham-Number | 3 | |||||
| Price-to-Net-Current-Asset-Value | 10.9 | |||||
| Price-to-Net-Cash | 28.67 | |||||
Earnings Yield (Greenblatt) % | 2.35 | |||||
FCF Yield % | 1.08 | |||||
Forward Rate of Return (Yacktman) % | 0.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guangdong Marubi Biotechnology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 3,493.959 | ||
| EPS (TTM) (Â¥) | 0.53 | ||
| Beta | 0.7506 | ||
| 3-Year Sharpe Ratio | -0.07 | ||
| 3-Year Sortino Ratio | -0.12 | ||
| Volatility % | 29.15 | ||
| 14-Day RSI | 47.26 | ||
| 14-Day ATR (Â¥) | 2.152315 | ||
| 20-Day SMA (Â¥) | 30.1155 | ||
| 12-1 Month Momentum % | -29.72 | ||
| 52-Week Range (Â¥) | 21.2 - 45.76 | ||
| Shares Outstanding (Mil) | 401 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guangdong Marubi Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guangdong Marubi Biotechnology Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.250000 Cash Dividend | 2026-07-16 | 28.86 (-1.67%) | ||
| CNY 0.250000 Cash Dividend | 2025-11-14 | 34.07 (-0.84%) | ||
| CNY 0.500000 Cash Dividend | 2025-06-10 | 45.76 (+0.70%) | ||
| CNY 0.250000 Cash Dividend | 2024-11-18 | 30.80 (-0.65%) |
Show
Entries
Guangdong Marubi Biotechnology Co Ltd Frequently Asked Questions
What is Guangdong Marubi Biotechnology Co Ltd(SHSE:603983)'s stock price today?
The current price of SHSE:603983 is ¥28.67. The 52 week high of SHSE:603983 is ¥45.76 and 52 week low is ¥21.20.
When is next earnings date of Guangdong Marubi Biotechnology Co Ltd(SHSE:603983)?
The next earnings date of Guangdong Marubi Biotechnology Co Ltd(SHSE:603983) is .
Does Guangdong Marubi Biotechnology Co Ltd(SHSE:603983) pay dividends? If so, how much?
The Dividend Yield %  of Guangdong Marubi Biotechnology Co Ltd(SHSE:603983) is 1.66% (As of Today), Highest Dividend Payout Ratio of Guangdong Marubi Biotechnology Co Ltd(SHSE:603983) was 1.4. The lowest was 0.39. And the median was 0.67. The  Forward Dividend Yield % of Guangdong Marubi Biotechnology Co Ltd(SHSE:603983) is 1.66%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Guangdong Marubi Biotechnology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers